Embecta Corp.
EMBCNasdaq
$3.25
↓ -3.0%Jul 17 close · end-of-day
Price
1Y↓ -65.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$192.7M
Enterprise Value
$1.3B
P/E
1.7
P/S
0.2
P/B
—
EV/EBITDA
4.3
PEG
—
FCF Yield
106.2%
Dividend Yield
18.5%
Revenue (TTM)
$1.0B
Net Income (TTM)
$111.9M
Free Cash Flow (TTM)
$204.7M
Gross Margin
61.9%
Operating Margin
25.8%
Net Margin
10.7%
ROE
-17.9%
ROIC
34.4%
Debt / Equity
-2.1
Net Cash
-$1.1B
Return 1Y
-65.6%
Company profile
Embecta Corp. focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications. The company primarily sells its products to wholesalers and distributors in the United States and internationally.
- CEO
- Devdatt Kurdikar
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 1,900
- Headquarters
- Delaware
- Website
- embecta.com
Management & directors
- Roth Anthony M.VP, Chief Accounting Officer
- Casner JeanChief Human Resources Officer
- Curtis ShaunSVP, Global Manuf./Sup. Chain
- Elguicze JacobSVP and CFO
- Kurdikar DevdattPresident and CEO
- Mann Jeffrey ZSVP, GC, Head Corp. Dev., Secy
Roles derived from SEC Form 4 filings.
Earnings
EMBC Q2 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$221.8M↓ -14.4%
Diluted EPS-$0.07↓ -117.5%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.2B | $1.1B | $1.1B | $1.1B | $1.1B |
| Gross profit | $762.6M | $800.4M | $774.9M | $749.9M | $735.2M | $676.8M |
| Operating income | $486.5M | $492.0M | $309.6M | $221.5M | $166.8M | $242.1M |
| Net income | $427.6M | $414.8M | $223.6M | $70.4M | $78.3M | $95.4M |
| Diluted EPS | $7.50 | $7.28 | $3.89 | $1.22 | $1.34 | $1.62 |
| Operating cash flow | $498.5M | $456.3M | $412.2M | $67.7M | $35.7M | $191.7M |
| Free cash flow | $456.6M | $419.5M | $388.6M | $41.2M | $19.9M | $182.4M |
| Gross margin | 70.3% | 68.7% | 68.6% | 66.9% | 65.5% | 62.6% |
| Operating margin | 44.8% | 42.2% | 27.4% | 19.8% | 14.9% | 22.4% |
| Net margin | 39.4% | 35.6% | 19.8% | 6.3% | 7.0% | 8.8% |
| Line item | Q3 '24 | Q4 '24 | Q1 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '25 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $272.5M | $286.1M | $261.9M | $259.0M | $295.5M | $264.0M | $261.2M | $221.8M |
| Gross profit | $190.1M | $173.8M | $157.1M | $164.1M | $197.1M | $158.5M | $161.7M | $127.8M |
| Operating income | $55.9M | $26.2M | $28.7M | $62.9M | $94.0M | $56.5M | $83.3M | $35.0M |
| Net income | $14.7M | $14.6M | $0.00 | $23.5M | $45.5M | $26.4M | $44.1M | -$4.1M |
| Diluted EPS | $0.25 | $0.24 | $0.00 | $0.40 | $0.78 | $0.44 | $0.74 | -$0.07 |
| Operating cash flow | -$2.1M | $26.6M | -$5.3M | $31.8M | $81.2M | $84.0M | $17.2M | $31.1M |
| Free cash flow | -$11.8M | $26.6M | -$6.8M | $31.7M | $80.8M | $76.7M | $16.6M | $30.6M |
| Gross margin | 69.8% | 60.7% | 60.0% | 63.4% | 66.7% | 60.0% | 61.9% | 57.6% |
| Operating margin | 20.5% | 9.2% | 11.0% | 24.3% | 31.8% | 21.4% | 31.9% | 15.8% |
| Net margin | 5.4% | 5.1% | 0.0% | 9.1% | 15.4% | 10.0% | 16.9% | -1.8% |
Company news
Jul 15, 2026
Jun 16, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-01 | Roth Anthony M.· VP, Chief Accounting Officer | Award | 30,000 | $0.00 | $0.00 | filing |
| 2026-02-11 | Prange Karen | Award | 22,841 | $0.00 | $0.00 | filing |
| 2026-02-11 | Pomeroy Claire | Award | 22,841 | $0.00 | $0.00 | filing |
| 2026-02-11 | Reidy Christopher R | Award | 22,841 | $0.00 | $0.00 | filing |
| 2026-02-11 | Anderson Carrie L | Award | 22,841 | $0.00 | $0.00 | filing |
| 2026-02-11 | Morris Milton Mayo | Award | 22,841 | $0.00 | $0.00 | filing |
| 2026-02-11 | HOMBACH ROBERT J. | Award | 22,841 | $0.00 | $0.00 | filing |
| 2025-11-26 | Kurdikar Devdatt· President and CEO | Tax withholding | 128,630 | $12.57 | $1.6M | filing |
| 2025-11-26 | Elguicze Jacob· SVP and CFO | Tax withholding | 24,782 | $12.57 | $311,509.74 | filing |
| 2025-11-26 | Mann Jeffrey Z· SVP, GC, Head Corp. Dev., Secy | Tax withholding | 19,605 | $12.57 | $246,434.85 | filing |
| 2025-11-26 | Curtis Shaun· SVP, Global Manuf./Sup. Chain | Tax withholding | 15,380 | $12.57 | $193,326.60 | filing |
| 2025-11-26 | Casner Jean· Chief Human Resources Officer | Tax withholding | 3,325 | $12.57 | $41,795.25 | filing |
| 2025-11-26 | Roth Anthony M.· Chief Accounting Officer | Tax withholding | 1,881 | $12.57 | $23,644.17 | filing |
| 2025-11-26 | Mann Jeffrey Z· SVP, GC, Head Corp. Dev., Secy | Award | 24,495 | $0.00 | $0.00 | filing |
| 2025-11-26 | Roth Anthony M.· Chief Accounting Officer | Award | 32,817 | $0.00 | $0.00 | filing |
| 2025-11-26 | Casner Jean· Chief Human Resources Officer | Award | 38,783 | $0.00 | $0.00 | filing |
| 2025-11-26 | Mann Jeffrey Z· SVP, GC, Head Corp. Dev., Secy | Award | 79,555 | $0.00 | $0.00 | filing |
| 2025-11-26 | Kurdikar Devdatt· President and CEO | Award | 288,386 | $0.00 | $0.00 | filing |
| 2025-11-26 | Kurdikar Devdatt· President and CEO | Award | 103,626 | $0.00 | $0.00 | filing |
| 2025-11-26 | Elguicze Jacob· SVP and CFO | Award | 95,466 | $0.00 | $0.00 | filing |
| 2025-11-26 | Elguicze Jacob· SVP and CFO | Award | 30,147 | $0.00 | $0.00 | filing |
| 2025-11-26 | Curtis Shaun· SVP, Global Manuf./Sup. Chain | Award | 37,789 | $0.00 | $0.00 | filing |
| 2025-11-26 | Curtis Shaun· SVP, Global Manuf./Sup. Chain | Award | 11,305 | $0.00 | $0.00 | filing |
| 2025-08-09 | Casner Jean· Chief Human Resources Officer | Tax withholding | 916 | $12.28 | $11,248.48 | filing |
Latest 24 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.